These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25684070)

  • 1. Does serotonin deficit mediate susceptibility to ADHD?
    Banerjee E; Nandagopal K
    Neurochem Int; 2015 Mar; 82():52-68. PubMed ID: 25684070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Miller EM; Pomerleau F; Huettl P; Gerhardt GA; Glaser PE
    Psychopharmacology (Berl); 2014 Aug; 231(15):3019-29. PubMed ID: 24682500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
    Umehara M; Ago Y; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Eur J Pharmacol; 2013 Feb; 702(1-3):250-7. PubMed ID: 23376565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder.
    Riley TB; Overton PG
    Med Hypotheses; 2019 Dec; 133():109407. PubMed ID: 31586811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).
    dela Peña I; Kim HJ; Sohn A; Kim BN; Han DH; Ryu JH; Shin CY; Noh M; Cheong JH
    Behav Brain Funct; 2014 May; 10():17. PubMed ID: 24884696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
    Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
    Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of 5-HT transporter density and long-term effects of methylphenidate in an animal model of ADHD.
    Roessner V; Manzke T; Becker A; Rothenberger A; Bock N
    World J Biol Psychiatry; 2009; 10(4 Pt 2):581-5. PubMed ID: 19172439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior.
    Dela Peña I; Bang M; Lee J; de la Peña JB; Kim BN; Han DH; Noh M; Shin CY; Cheong JH
    Behav Brain Res; 2015 Sep; 291():268-276. PubMed ID: 26048425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
    Hong Q; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
    J Neurol Sci; 2009 Dec; 287(1-2):205-11. PubMed ID: 19709672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample.
    Hawi Z; Dring M; Kirley A; Foley D; Kent L; Craddock N; Asherson P; Curran S; Gould A; Richards S; Lawson D; Pay H; Turic D; Langley K; Owen M; O'Donovan M; Thapar A; Fitzgerald M; Gill M
    Mol Psychiatry; 2002; 7(7):718-25. PubMed ID: 12192616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder.
    Quist JF; Barr CL; Schachar R; Roberts W; Malone M; Tannock R; Basile VS; Beitchman J; Kennedy JL
    Mol Psychiatry; 2003 Jan; 8(1):98-102. PubMed ID: 12556913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
    Marsden CA
    Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.